CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

CVS Health Corporation

In a report released today, from Berenberg Bank reiterated a Buy rating on CVS Group plc, with a price target of p2,000.00. The word on The Street ...

Berenberg Bank Keeps Their Buy Rating on CVS Group plc (CVSG)

Insiders have been trading these 5 stocks: (($RIVN)), (($CVS)), (($NOW)), (($DKNG)) and (($AMC)). Here is a breakdown of their recent trades and th...

Insider Shockwaves: Rivian, CVS, ServiceNow, DraftKings, AMC

Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health today and set a price target of $103.00. According to TipRanks, Baxter is ...

Wells Fargo Keeps Their Buy Rating on CVS Health (CVS)

CVS Health ( ($CVS) ) has shared an update. At its May 14, 2026 annual meeting, CVS Health stockholders approved a new 2026 Incentive Compensation ...

CVS Health Shareholders Approve New 2026 Incentive Plan

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CVS Health (CVS), BioMarin Pharmaceutical (BMRN) and...

Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), BioMarin Pharmaceutical (BMRN) and AbbVie (ABBV)

Insiders have been trading these 5 stocks: (($JPM)), (($MSTR)), (($C)), (($RKLB)) and (($CVS)). Here is a breakdown of their recent trades and thei...

JPMorgan, Strategy, Citigroup, Rocket Lab, CVS Insider Shock

CV Sciences (($CVSI)) has held its Q1 earnings call. Read on for the main highlights of the call. CV Sciences’ latest earnings call painted a cauti...

CV Sciences Earnings Call: Progress Amid CBD Headwinds

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Agilon Health (AGL) and CVS Health (CVS). Agilon Health (AGL) In ...

Analysts Conflicted on These Healthcare Names: Agilon Health (AGL) and CVS Health (CVS)

Mizuho Securities analyst Ann Hynes maintained a Buy rating on CVS Health on May 8 and set a price target of $102.00. The company’s shares closed l...

Mizuho Securities Sticks to Its Buy Rating for CVS Health (CVS)

Barrington analyst Alexander Paris reiterated a Buy rating on Covista today and set a price target of $170.00. According to TipRanks, Paris is a 5-...

Covista (CVSA) Gets a Buy from Barrington

RBC Capital analyst Ben Hendrix reiterated a Buy rating on CVS Health yesterday and set a price target of $107.00. The company’s shares closed yest...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CVS	$90.73	-2.71%	5.62M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CVS	$90.73	-2.7%	5.62M
3
4
5
6

CVS

CVS

Get CVS Health Corporation Data in Excel

Get CVS Health Corporation Data in Excel